adagrasib
mirati
['lcsm,(-blcsm)', 'adagrasib']
vogl new york is back! updated data on adagrasib in the ph i study of this agent demonstrates an orr of 43%, deep responses of &gt;50% in responders. what a waterfall #lcsm #asco22 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity. Beaumont RCSI Cancer Centre Dublin; Adjunct Asst Prof Johns Hopkins University